Christian S Marchello
Overview
Explore the profile of Christian S Marchello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
270
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martin L, Tack B, Marchello C, Sikorski M, Owusu-Dabo E, Nyirenda T, et al.
Vaccine
. 2024 Jul;
42(19S1):S101-S124.
PMID: 39003017
Invasive non-typhoidal Salmonella (iNTS) disease is an under-recognized high-burden disease causing major health and socioeconomic issues in sub-Saharan Africa (sSA), predominantly among immune-naïve infants and young children, including those with...
2.
Kim J, Tack B, Fiorino F, Pettini E, Marchello C, Jacobs J, et al.
BMJ Open
. 2024 Mar;
14(3):e080501.
PMID: 38485477
Background: Invasive non-typhoidal (iNTS) disease is a significant health concern in sub-Saharan Africa. While our knowledge of a larger-scale variation is growing, understanding of the subnational variation in iNTS disease...
3.
Hagedoorn N, Murthy S, Birkhold M, Marchello C, Crump J
Epidemiol Infect
. 2023 Oct;
152:e4.
PMID: 37850326
To inform coverage by potential vaccines, we aimed to systematically review evidence on the prevalence and distribution of non-typhoidal serogroups and serovars. We searched four databases from inception through 4...
4.
Marchello C, Birkhold M, Crump J
Lancet Infect Dis
. 2022 Feb;
22(5):692-705.
PMID: 35114140
Background: Non-typhoidal salmonella can cause serious, life-threatening invasive infections involving the bloodstream and other normally sterile sites. We aimed to systematically review the prevalence of complications and case-fatality ratio (CFR)...
5.
Oo W, Carr S, Marchello C, San M, Oo A, Oo K, et al.
Infect Prev Pract
. 2022 Jan;
4(1):100197.
PMID: 35005602
Background: Antimicrobial resistance is increasingly prevalent worldwide. The inappropriate use of antimicrobials, including in the hospital setting, is considered a major driver of antimicrobial resistance. Aim: To inform improvements in...
6.
Marchello C, Fiorino F, Pettini E, Crump J
J Infect
. 2021 Jul;
83(5):523-532.
PMID: 34260964
Objectives: We sought to collate and summarize high-quality data on non-typhoidal Salmonella invasive disease (iNTS) incidence to provide contemporary incidence estimates by location and year. Methods: We systematically searched the...
7.
Marchello C, Birkhold M, Crump J
J Infect
. 2020 Nov;
81(6):902-910.
PMID: 33144193
Objectives: Updated estimates of the prevalence of complications and case fatality ratio (CFR) among typhoid fever patients are needed to understand disease burden. Methods: Articles published in PubMed and Web...
8.
Marchello C, Carr S, Crump J
Am J Trop Med Hyg
. 2020 Sep;
103(6):2518-2527.
PMID: 32996447
Understanding patterns and trends of antimicrobial resistance (AMR) in Typhi can guide empiric treatment recommendations and contribute to country decisions about typhoid conjugate vaccine (TCV) introduction. We systematically reviewed PubMed...
9.
Marchello C, Dale A, Pisharody S, Rubach M, Crump J
Antimicrob Agents Chemother
. 2019 Oct;
64(1).
PMID: 31636071
Community-onset bloodstream infections (CO-BSI) are major causes of severe febrile illness and death worldwide. In light of new data and the growing problem of antimicrobial resistance (AMR) among pathogens causing...
10.
Marchello C, Dale A, Pisharody S, Crump J
Trop Med Int Health
. 2019 Oct;
24(12):1369-1383.
PMID: 31633858
Objectives: Hospital-based studies of community-onset bloodstream infections (CO-BSI) are less resource-intensive to carry out than population-based incidence studies. We examined several metrics capturing the potential role of Salmonella Typhi as...